Balancing weight reduction benefits and risks: implications for serum urate management. Comment on the article by Fukui et al

Documenti analoghi

• Determinants of achieving serum urate goal with treat‐to‐target urate‐lowering therapy in gout: comment on the article by Helget et al
  di: Daniel Small
  Pubblicazione: (2024)
• Refining the interpretation of drug survival and safety in VEXAS syndrome: the importance of competing risks and exposure time. Comment on the article by Eviatar et al
  di: Yi Pei, et al.
  Pubblicazione: (2026)
• Is serum uric acid a mere bystander or an active player in osteoarthritis pathogenesis? Comment on the article by Xu et al
  di: Fangying Wu, et al.
  Pubblicazione: (2026)
• An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al
  di: Ling Zhang, et al.
  Pubblicazione: (2024)
• Potential Confounding by Weight Loss: Comment on the article by Jorge et al.
  di: Eylul Kizkapan, et al.
  Pubblicazione: (2026)